Reuters – 3SBio to Go Private in $340M Deal

Chinese biotechnology firm 3SBio Inc. said it agreed to be bought by Decade Sunshine Ltd. for about $340 million, Reuters reported. The offer of $15.40 per American Depositary Shares is at a premium of about 12 percent to the ADS’s Thursday close of $13.79.

(Reuters) – Chinese biotechnology firm 3SBio Inc said it agreed to be bought by Decade Sunshine Ltd for about $340 million.

The offer of $15.40 per American Depositary Shares (ADS) is at a premium of about 12 percent to the ADS’s Thursday close of $13.79.

3SBio Chief Executive Jing Lou had offered to take the company private for up to $15 per ADS, or about $331 million, last September.

Related Posts

Leave a Reply

PEHUB Community

Join the 12500 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget